- Home
- EXPI vs KROS Comparison
EXPI vs KROS Comparison
Compare EXPI & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPI
- KROS
- Stock Information
- Founded
- EXPI 2008
- KROS 2015
- Country
- EXPI United States
- KROS United States
- Employees
- EXPI N/A
- KROS N/A
- Industry
- EXPI Real Estate
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- EXPI Finance
- KROS Health Care
- Exchange
- EXPI Nasdaq
- KROS Nasdaq
- Market Cap
- EXPI 2.2B
- KROS 1.8B
- IPO Year
- EXPI N/A
- KROS 2020
- Fundamental
- Price
- EXPI $13.25
- KROS $53.84
- Analyst Decision
- EXPI Hold
- KROS Strong Buy
- Analyst Count
- EXPI 2
- KROS 8
- Target Price
- EXPI $13.50
- KROS $91.43
- AVG Volume (30 Days)
- EXPI 818.9K
- KROS 407.2K
- Earning Date
- EXPI 11-07-2024
- KROS 11-06-2024
- Dividend Yield
- EXPI 1.52%
- KROS N/A
- EPS Growth
- EXPI N/A
- KROS N/A
- EPS
- EXPI N/A
- KROS N/A
- Revenue
- EXPI $4,458,228,000.00
- KROS $651,000.00
- Revenue This Year
- EXPI $8.76
- KROS $1,232.45
- Revenue Next Year
- EXPI $7.62
- KROS $126.39
- P/E Ratio
- EXPI N/A
- KROS N/A
- Revenue Growth
- EXPI 5.50
- KROS 8037.50
- 52 Week Low
- EXPI $8.91
- KROS $27.31
- 52 Week High
- EXPI $17.11
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- EXPI 47.87
- KROS 35.08
- Support Level
- EXPI $12.32
- KROS $52.64
- Resistance Level
- EXPI $14.85
- KROS $70.26
- Average True Range (ATR)
- EXPI 0.80
- KROS 3.40
- MACD
- EXPI -0.13
- KROS -1.42
- Stochastic Oscillator
- EXPI 32.07
- KROS 6.84
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.